BioNTech and Pfizer score win in UPC dispute over COVID-19 vaccines against Promosome
Promosome, acting on behalf of the exclusive licensee and patent holder Scripps Research Institute, brought the proceedings before the UPC at the end of 2024. It accuses BioNTech and its US partner…
Read the full articleYou might also wanna read
Align and Carpmaels & Ransford defend PI in dental aligner technology
JUVE Patent·5h ago
Mewburn Ellis strengthens patent litigation team with SEP specialist
JUVE Patent·2d ago
Munich Regional Court finds Innoscience GaN chips infringe further Infineon patent
JUVE Patent·2d ago
Hologic and Vossius take action against Siemens Healthineers over mammography system
JUVE Patent·3d ago
UPC Court of Appeal strengthens central division in windscreen wiper dispute
JUVE Patent·6d ago
HGF adds two in-house life sciences partners in Basel and Bristol
JUVE Patent·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.